Unity Biotechnology Inc (UBX) PT Lowered to $10 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Price: $0.20 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Unity Biotechnology Inc (NASDAQ: UBX) to $10.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ethos Technologies (LIFE) PT Raised to $55 at Citizens on 'Very Strong' Q3 Results
- Iovanace Biotherapeutics (IOVA) PT Raised to $8 at UBS
- IDEXX Laboratories (IDXX) PT Raised to $700 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
